At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment
In Brief
A clinical study evaluating Genome Informed Risk Assessment (GIRA) report for Genetic Disease. Active but no longer recruiting, targeting 26,877 participants across 12 sites.
Detailed Summary
The eMERGE Network embraces the opportunity to use new methods in genomic medicine, information science, and research participant engagement to identify people at very high risk for specific diseases and recommend individualized approaches to prevention and care. The investigators will conduct a prospective study, with diverse and underserved participants, across ten eMERGE study sites to evaluate clinical implementation of a Genome Informed Risk Assessment (GIRA) tool that combines genetic, family history, and clinical risk information from participants.
Study Details
Timeline
Interventions
A Genome Informed Risk Assessment (GIRA) report that combines genetic (monogenic risks and polygenic risk scores), family history, and clinical risk information from participants.